Specific aspects of peritoneal dialysis in diabetic patients;Specifické aspekty peritoneální dialýzy u diabetiků

Vnitrni Lekarstvi

Volumn 54, Issue 5, 2008, Pages 523-529

  Opatrná, Sylvie ^a   Klaboch, J ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Chronic renal failure; Diabetes mellitus; Peritoneal dialysis; Peritonitis

Indexed keywords

AMINO ACID DERIVATIVE; GLUCOSE DEGRADATION PRODUCT; ICODEXTRIN;

ARTICLE; CHRONIC KIDNEY FAILURE; COMORBIDITY; DIABETES MELLITUS; DIABETIC PATIENT; HEMODIALYSIS; HUMAN; INCIDENCE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MORTALITY; PERITONEAL DIALYSIS; PERITONITIS; RENAL REPLACEMENT THERAPY; SURVIVAL RATE;

DIABETIC NEPHROPATHIES; HUMANS; KIDNEY FAILURE, CHRONIC; PERITONEAL DIALYSIS; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PERITONITIS;

EID: 45149127345     PISSN: 0042773X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Ahmad S, Sehmi JS, Ahmad-Zakhi KH et al. Impact of new dialysis solutions on peritonitis rates. Kidney Int 2006; 70: S63-S66.
2. Chou MY, Kao MT, Lai MN et al. Comparisons of the peritoneal equilibration test and ultrafiltration in patients with and without diabetes mellitus on continuous ambulatory peritoneal dialysis. Am J Nephrol 2006; 26: 87-90.
3. Chow KM, Szeto CC, Leung CB et al. A risk analysis of continuous ambulatory peritoneal dialysis-related peritonitis. Perit Dial Int 2005; 25: 374-379.
4. Chung SH, Chu WS, Lee HA et al. Peritoneal transport characteristics, comorbid diseases and survival in CAPD patients. Perit Dial Int 2000; 20: 541-547.
5. Churchill DN, Taylor DW, Keshaviah PR (for the CANUSA Peritoneal Dialysis Study Group). Adequacy of dialysis and nutrition in continuous peritoneal dialysis. Association with clinical outcomes. J Am Soc Nephrol 1996; 7: 198-207.
6. Collins AJ, Hao W, Xia H et al. Mortality risks of peritoneal dialysis and hemodialysis. Am J Kidney Dis 1999; 34: 1065-1074.
7. Dombros N, Dratwa M, Feriani M et al. EBPG Expert Group on Peritoneal Dialysis. European best practice guidelines for peritoneal dialysis. 3 Peritoneal access. Nephrol Dial Transplant 2005; 20(Suppl 9): ix8-ix12.
8. Fried L, Piraino B. Peritonitis. In: Gokal R, Khanna R, Krediet RT (eds). Textbook of Peritoneal Dialysis. Dordrecht, Boston, London: Kluwer Academic Publishers 2000: 545-564.
9. Ganesh SK, Julber-Shearon T, Port FK et al. Mortality differences by dialysis modality among incident ESRD patients with and without coronary artery disease. J Am Soc Nephrol 2003; 14: 415-424.
10. Gillerot G, Goffin E, Michel C et al. Genetic and clinical factors influence the baseline permeability of the peritoneal membrane. Kidney Int 2005; 67: 2477-2487.
11. Grassmann A, Gioberge S, Moeller S et al. ESRD patients in 2004: Global overview of patient numbers, treatment modalities and associated trends. Nephrol Dial Tranplant 2005; 20: 2578-2593.
12. Hájková B, Fixa P. Současné trendy v léčbě peritonitid u nemocných léč ených peritoneální dialýzou. Vnitř Lék 2004; 50: 619-623.
13. Heaf JG, Lokkegaard H, Madsen M. Initial survival advantage of peritoneal dialysis relative to haemodialysis. Nephrol Dial Transplant 2002; 17: 112-117.
14. Jaar BG, Coresh J, Plantinga LC et al. Comparing the risk of death with peritoneal dialysis and hemodialysis in a national cohort of patients with chronic kidney disease. Ann Intern med 2005; 143: 174-183.
15. Konings CJ, Kooman JP, Schonck M et al. Effect of icodextrin on volume status, blood pressure and echocardiographic parameters: a randomized study. Kidney Int 2003; 63: 1556-1563.
16. Kopple JD, Bernard D, Messana J et al. Treatment of malnourished CAPD patients with an amino acid based dialysate. Kidney Int 1995; 47: 1148-1157.
17. Krediet RT. Peritoneal Solute Transport and Ultrafiltration. In: Gokal R, Khanna R, Krediet RT (eds). Textbook of Peritoneal Dialysis. Dordrecht, Boston, London: Kluwer Academic Publishers 2000: 135-172.
18. Lee HY, Choi HY, Park HC et al. Changing prescribing practice in CAPD patients in Korea: increased utilization of low GDP solutions improves patient outcome. Nephrol Dial Transplant 2006; 21: 2893-2899.
19. Liem YS, Wong JB, Hunink MGM et al. Comparison of hemodialysis and peritoneal dialysis survival in The Netherlands. Kidney Int 2007; 71: 153-158.
20. Marshall J, Jennings P, Scott A et al. Glycemic control in diabetic CAPD patients assessed by continuous glucose monitoring system (CGMS). Kidney Int 2003; 64: 1480-1486.
21. Mehrotra R. Peritoneal dialysis penetration in the United States: march toward the fringes? Perit Dial Int 2006; 26: 419-422.
22. Mistry CD, Gokal R, Peers EM. A randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD. MIDAS Study Group. Multicenter investigation of icodextrin in ambulatory peritoneal dialysis. Kidney Int 1994; 46: 496-503.
23. Montenegro J, Saracho R, Gallardo I et al. Use of pure bicarbonate-buffered peritoneal dialysis fluid reduces the incidence of CAPD peritonitis. Nephrol Dial Transplant 2007; 22: 1703-1708.
24. Mujais S. Microbiology and outcomes of peritonitis in North America. Kidney Int 2006; 70(Supl 103): 55-62.
25. Murphy SW, Foley RN, Barrett BJ et al. Comparative mortality of hemodialysis and peritoneal dialysis in Canada. Kidney Int 2000; 57: 1720-1726.
26. Nissenson AR, Prichard SS, Cheng IK et al. ESRD modality selection into the 21st century: the importance of non medical factors. ASAIO J 1997; 43: 143-150.
27. Oo TN, Roberts TL, Collins AJ. A comparison of peritonitis rates from the United States Renal Data System database: CAPD versus continuous cycling peritoneal dialysis patients. Am J Kidney Dis 2005; 45: 372-380.
28. Opatrná S, Šefrna F. Development of peritoneal dialysis and renal replacement therapy in the Czech Republic since the postcomunist transition. Perit Dial Int 2007; 27: 196-202.
29. Opatrná S. Lze dále snižovat výskyt peritonitidy sdružené s peritoneální dialýzou? Vnitř Lék 2004; 50: 578-581.
30. Opatrná S, Racek J, Stehlik P et al. Vliv podání dialyzačního roztoku s icodextrinem na ultrafiltraci a vybrané metabolické parametry nemocných léčených peritoneální dialýzou. Čas Lék Čes 2002; 141: 281-285.
31. Opatrná S, Liška J, Vít L et al. Vliv dialyzačního roztoku s obsahem aminokyselin na nutriční stav nemocných léčených kontinuální ambulantní peritoneální dialýzou (CAPD). Čas Lék Čes 1997; 136: 409-412.
32. Opatrný K jr. Zamy̌slení nad současným stavem chronické dialýzy v České republice. Akt Nefrol 1995; 2: 11-14.
33. Piraino B, Bailie GR, Bernardini J et al. ISPD Guidelines/ Recommendations. Peritoneal dialysis-related infections Recommendations: 2005 Update. Per Dial Int 2005; 25: 107-131.
34. Shemin D, Bostom AG, Laliberty P et al. Residual renal function and mortality risk in hemodialysis patients. Am J Kidney Dis 2001; 38: 85-90.
35. Stack AG, Molony DA, Rahman NS et al. Impact of dialysis modality on survival of new ESRD patients with congestive hear failure in the United States. Kidney Int 2003; 64: 1071-1079.
36. Termorshuizen F, Korevaar JC, Dekker FW et al. Hemodialysis and peritoneal dialysis: comparison of adjusted mortality rates according to the duration of dialysis. Analysis of The Netherlands Cooperative Study on the Adequacy of dialysis 2. J Am Soc Nephrol 2003; 14: 2851-2860.
37. Twardowski ZJ. Clinical value of standardized equilibration tests in CAPD patients. Blood Purif 1989; 7: 95-108.
38. U.S. Renal Data System. Excerpts from the USRDS 2006 Annual Data Report. Am J Kidney Dis 2007; 49: 129-147.
39. Van Vlem B, Schoonjans RS, Struijk DG et al. Influence of dialysate on gastric emptying time in peritoneal dialysis patients. Per Dial Int 2002; 22: 32-38.
40. Vonesh EF, Snyder JJ, Foley RN et al. The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis. Kidney Int 2004; 66: 2389-2401.